| Tuoketuo |
| Shangdu | ||||||||||
Blindness | SVI | MVI |
| Blindness | SVI | MVI | |||||||
n = 24 | n = 20 | n = 87 |
| n = 30 | n = 40 | n = 91 | |||||||
Refractive error | 0 | 0.0% | 5 | 25.0% | 44 | 50.6% |
| 2 | 6.7% | 7 | 17.5% | 42 | 46.2% |
Aphakia, uncorrected | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
| 0 | 0.0% | 0 | 0.0% | 1 | 1.1% |
Cataract, untreated | 15 | 62.5% | 10 | 50.0% | 28 | 32.2% |
| 14 | 46.7% | 13 | 32.5% | 23 | 25.3% |
Total treatable | 15 | 62.5% | 15 | 75.0% | 72 | 82.8% |
| 16 | 53.3% | 20 | 50.0% | 66 | 72.5% |
Other corneal opacity | 1 | 4.2% | 0 | 0.0% | 1 | 1.1% |
| 6 | 20.0% | 3 | 7.5% | 2 | 2.2% |
Myopic retinopathy | 3 | 12.5% | 2 | 10.0% | 4 | 4.6% |
| 0 | 0.0% | 10 | 25.0% | 8 | 8.8% |
Total preventable | 4 | 16.7% | 2 | 10.0% | 5 | 5.7% |
| 6 | 20.0% | 13 | 32.5% | 10 | 11.0% |
Cataract surgical complications | 2 | 8.3% | 1 | 5.0% | 2 | 2.3% |
| 0 | 0.0% | 1 | 2.5% | 1 | 1.1% |
Glaucoma | 2 | 8.3% | 0 | 0.0% | 1 | 1.1% |
| 1 | 3.3% | 1 | 2.5% | 0 | 0.0% |
Diabetic retinopathy | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
| 0 | 0.0% | 0 | 0.0% | 2 | 2.2% |
Total avoidable | 23 | 95.8% | 18 | 90.0% | 80 | 92.0% |
| 23 | 76.7% | 35 | 87.5% | 78 | 85.7% |
ARMD | 0 | 0.0% | 0 | 0.0% | 3 | 3.4% |
| 0 | 0.0% | 1 | 2.5% | 6 | 6.6% |
Other posterior segment | 1 | 4.2% | 1 | 5.0% | 3 | 3.4% |
| 5 | 16.7% | 4 | 10.0% | 7 | 7.7% |
Globe abnormality/CNS | 0 | 0.0% | 1 | 5.0% | 1 | 1.1% |
| 2 | 6.7% | 0 | 0.0% | 0 | 0.0% |